Skip to content

13F-HR filed by SECTORAL ASSET MANAGEMENT INC

SECTORAL ASSET MANAGEMENT INC filed this 13F-HR for the quarter ended 2017-06-30, filed 2017-08-14, with 61 holding rows worth $914,419,000.

Accession
0001104659-17-051739
Filed
2017-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2017

A holdings report, 61 entries on the cover page, a total value of $914,419,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $914,419,000 with VALUE read as thousands by filing date, 13F file number 028-10653. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Pfizer Inc.717081103COM1,405,970$47,227,000thousands by filing date
Johnson & Johnson478160104COM354,048$46,837,000thousands by filing date
Merck & Co.,Inc.58933Y105COM729,483$46,753,000thousands by filing date
NOVARTIS AG SPONSORED ADR66987V109ADR559,296$46,684,000thousands by filing date
Medtronic PlcG5960L103COM398,360$35,354,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM3,483,990$35,084,000thousands by filing date
ABIOMED INC003654100COM229,272$32,855,000thousands by filing date
REGENERON PHARMACEUTICALS COM75886F107Stock62,898$30,892,000thousands by filing date
ACADIA PHARMACEUTICALS INC004225108COM1,098,809$30,646,000thousands by filing date
CELGENE CORP151020104COM233,768$30,359,000thousands by filing date
NUVASIVE INC670704105COM393,289$30,252,000thousands by filing date
ACADIA HEALTHCARE COMPANY INC COM00404A109Stock603,210$29,787,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM313,382$28,461,000thousands by filing date
K2M GROUP HLDGS INC48273J107COM1,028,219$25,047,000thousands by filing date
DEXCOM INC COM252131107Stock333,341$24,384,000thousands by filing date
PORTOLA PHARMACEUTICALS INC COM737010108Stock422,143$23,712,000thousands by filing date
COLLEGIUM PHARMACEUTICAL INC19459J104COM1,808,750$22,627,000thousands by filing date
AERIE PHARMACEUTICALS INC00771V108COM402,674$21,161,000thousands by filing date
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR602,279$20,008,000thousands by filing date
MYLAN NVN59465109SHS EURO495,804$19,247,000thousands by filing date
EDWARDS LIFESCIENCES CORP COM28176E108Stock160,380$18,963,000thousands by filing date
TELADOC HEALTH INC87918A105COM543,073$18,845,000thousands by filing date
ACCELERON PHARMA INC00434H108COM604,499$18,371,000thousands by filing date
LOXO ONCOLOGY INC548862101COM221,795$17,786,000thousands by filing date
LA JOLLA PHARMACEUTICAL CO503459604COM PAR $.0001 2589,959$17,563,000thousands by filing date
Intuitive Surgical,Inc.46120E602COM16,467$15,403,000thousands by filing date
EVOLENT HEALTH INC CL A30050B101Stock532,812$13,507,000thousands by filing date
INTEGRA LIFESCIENCES HLDGS C457985208COM NEW243,998$13,300,000thousands by filing date
GLOBAL BLOOD THERAPEUTICS USD37890U108COM452,781$12,384,000thousands by filing date
NEUROCRINE BIOSCIENCES INC64125C109COM238,707$10,981,000thousands by filing date
NEURODERM LTDM74231107ORD SHS350,085$10,468,000thousands by filing date
WRIGHT MED GROUP N VN96617118ORD SHS373,622$10,271,000thousands by filing date
ENDO INTL PLCG30401106SHS820,699$9,167,000thousands by filing date
NXSTAGE MEDICAL INC67072V103COMMON STOCK349,709$8,767,000thousands by filing date
ENVISION HEALTHCARE CORP29414D100COM133,220$8,349,000thousands by filing date
PROTHENA CORP PLC SHSG72800108Stock151,046$8,175,000thousands by filing date
IRHYTHM HOLDINGS INC COM450056106Stock185,170$7,868,000thousands by filing date
MASIMO CORP COM574795100Stock73,300$6,683,000thousands by filing date
DBV TECHNOLOGIES S A23306J101ADR179,152$6,398,000thousands by filing date
AGIOS PHARMACEUTICALS INC00847X104COM123,599$6,359,000thousands by filing date
SPARK THERAPEUTICS INC84652J103COM101,300$6,052,000thousands by filing date
MOMENTA PHARMACEUTICALS INC60877T100COM299,400$5,060,000thousands by filing date
ALBIREO PHARMA INC01345P106COMMON STOCK188,712$3,887,000thousands by filing date
RA PHARMACEUTICALS INC74933V108COM178,750$3,350,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM31,900$2,987,000thousands by filing date
ILLUMINA INC452327109COM16,850$2,924,000thousands by filing date
ACCURAY INC DEL004397105COM588,347$2,795,000thousands by filing date
INCYTE CORP COM45337C102Stock21,845$2,751,000thousands by filing date
CIGNA CORPORATION125509109COM15,510$2,596,000thousands by filing date
INSMED INC COM PAR $.01457669307Stock145,799$2,502,000thousands by filing date
VERSARTIS INC92529L102COM104,757$1,828,000thousands by filing date
ObsEva SAH5861P103COM212,831$1,820,000thousands by filing date
IMMUNE DESIGN CORP.45252L103Common Stock168,300$1,641,000thousands by filing date
SPRING BK PHARMACEUTICALS IN849431101COM112,500$1,523,000thousands by filing date
PTC THERAPEUTICS INC69366J200COM60,735$1,113,000thousands by filing date
SAGE THERAPEUTICS INC78667J108COM12,199$972,000thousands by filing date
SAREPTA THERAPEUTICS INC803607100COM28,799$971,000thousands by filing date
TG THERAPEUTICS INC COM88322Q108Stock81,266$817,000thousands by filing date
TRILLIUM THERAPEUTICS INC COM NEW89620X506Stock183,272$806,000thousands by filing date
DR REDDYS LABS LTD ADR256135203ADR19,065$803,000thousands by filing date
SIERRA ONCOLOGY INC82640U107COM201,660$236,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001104659-17-051739this filing2017-08-14acceptance time not in the bulk data set